SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Ian@SI5/10/2013 3:38:47 PM
   of 3158
 
WCRX up about 25%

Actavis Inc. ( ACT ), a big maker of generic drugs that was an acquisition target a month ago, is in early talks about a potential acquisition of Irish drug maker Warner Chilcott PLC ( WCRX ), a person familiar with the matter said.

The talks come weeks after Valeant Pharmaceuticals International Inc. (VRX, VRX.T) sought to acquire Actavis in an all-stock deal. That deal didn't happen because of differences over the premium and other issues, people familiar with those discussions said at the time.

Read more: nasdaq.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News